本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pardes Biosciences Inc.

2.16
0.0000
成交量:- -
成交额:510.58万
市值:1.31亿
市盈率:-1.69
高:2.16
开:2.16
低:2.16
收:2.16
52周最高:3.67
52周最低:0.7500
股本:6,073.49万
流通股本:1,407.01万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.2811
每股收益(LYR):-1.6625
净资产收益率:-40.28%
总资产收益率:-26.49%
市净率:0.84
市盈率(LYR):-1.30

数据加载中...

2023/09/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/31

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/08/31

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/31

重要事件披露

Form 8-K - Current report
2023/08/31

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2023/08/29

SEC问询函

Form CORRESP - Correspondence
2023/08/28

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2023/08/18

SEC问询函

Form CORRESP - Correspondence
2023/08/17

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2023/08/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/29

私有化交易

Form SC 13E3 - Going private transaction by certain issuers
2023/07/17

重要事件披露

Form 8-K - Current report
2023/07/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/05

重要事件披露

Form 8-K - Current report
2023/05/18

重要事件披露

Form 8-K - Current report
2023/05/05

重要事件披露

Form 8-K - Current report
2023/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/21

重要事件披露

Form 8-K - Current report
2023/04/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]